TROUBLE VIEWING? Click Here to view the Promo card on the web
SIGN-UP NOW! SIGN-UP NOW! Click to become a Member for Free!
voiceamerica-health-and-wellness radio logo
Apple logo Google Play Store Kindle store
C. diff. Spores and More

C. diff. Spores and More

Tuesday at 10 AM Pacific

December 05th 2017: Encore: The Latest Developments in C. diff Research and Treatment.

Join us with our guest, Dr Mary Beth Dorr, PhD, Clinical Director, Clinical Research, Infectious Diseases,

Share Email SHARE
Download PDF DOWNLOAD PDF

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel
LISTEN LIVE
EPISODE ON DEMAND
VIEW HOST PAGE
Questions? Comments?
Call In Live!
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guest

Guest Image

Dr Mary Beth Dorr,PhD, Clinical Director Merck & Co., Inc.

Dr. Mary Beth Dorr is the product development lead for ZINPLAVA (bezlotoxumab), a human monoclonal antibody that binds to Clostridium difficile toxin B and neutralizes its effects.
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
Facebook Twitter Linkedin Social Media
presspass-banner